The expression levels of C6orf141 were determined to be significantly reduced in thyroid cancer and testicular cancer, whereas those of C6orf141 were determined to be increased in colon cancer and lung cancer (data not shown). This evidence concerns the gene C6orf141 and lung carcinoma.